Aktis Oncology, Inc. (AKTS)
NASDAQ·Healthcare·Biotechnology
$18.78
-6.52%
Mkt Cap $1.18B
Mkt Cap
$1.18B
P/E
—
Fwd P/E
—
P/S
60.97
Rev TTM
—
EPS TTM
-$0.81
NASDAQ·Healthcare·Biotechnology
$18.78
-6.52%
Mkt Cap $1.18B
Mkt Cap
$1.18B
P/E
—
Fwd P/E
—
P/S
60.97
Rev TTM
—
EPS TTM
-$0.81